Radiomedix

Radiomedix

Biotechnology, 9701 Richmond Ave, Houston, Texas, 77042, United States, 11-50 Employees

radiomedix.com

  • twitter
  • LinkedIn

phone no Phone Number: 71********

Who is RADIOMEDIX

RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is ...

Read More

map
  • 9701 Richmond Ave, Houston, Texas, 77042, United States Headquarters: 9701 Richmond Ave, Houston, Texas, 77042, United States
  • 2006 Date Founded: 2006
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from RADIOMEDIX

Radiomedix Org Chart and Mapping

Employees

William Petch

Quality Control Chemist

Ayda Delpassand

Head of Site Commercial Manufacturing/Quality Assurance

Alireza Norouzian

Sales & Support Supervisor

Alex Brow

Quality Assurance Specialist

Jesus Puente

Senior Research Associate

Mayte Anorve

Manufacturing Associate I

Nilesh Wagh

Associate Director-CMC Radiopharmaceutical Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Radiomedix

Answer: Radiomedix's headquarters are located at 9701 Richmond Ave, Houston, Texas, 77042, United States

Answer: Radiomedix's phone number is 71********

Answer: Radiomedix's official website is https://radiomedix.com

Answer: Radiomedix's revenue is $10 Million to $25 Million

Answer: Radiomedix's SIC: 8731

Answer: Radiomedix's NAICS: 541714

Answer: Radiomedix has 11-50 employees

Answer: Radiomedix is in Biotechnology

Answer: Radiomedix contact info: Phone number: 71******** Website: https://radiomedix.com

Answer: RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedixTM automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access